Literature DB >> 31338833

Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort.

Cyrielle Fouquet1, Marie-Amelyne Le Rouzic2, Thierry Leblanc3, Fanny Fouyssac2, Guy Leverger4, Laila Hessissen5, Sandrine Marlin6, Emmanuelle Bourrat7, Mony Fahd3, Emmanuel Raffoux7, Jean-Pierre Vannier8, Nadja Jäkel9, Ralf Knoefler10, Valerie Triolo11, Marlene Pasquet12, Sophie Bayart13, Isabelle Thuret14, Patrick Lutz15, Christiane Vermylen16, Mohamed Touati17, Christian Rose18, Thomas Matthes19, Bertrand Isidor20, Caroline Kannengiesser21, Stephane Ducassou1.   

Abstract

Congenital sideroblastic anaemia (CSA) is a rare disease caused by germline mutations of genes involved in haem and iron-sulphur cluster formation, and mitochondrial protein biosynthesis. We performed a retrospective multicentre European study of a cohort of childhood-onset CSA patients to explore genotype/phenotype correlations. We studied 23 females and 20 males with symptoms of CSA. Among the patients, the most frequently mutated genes were ALAS2 (n = 10; 23·3%) and SLC25A38 (n = 8; 18·6%), causing isolated forms of microcytic anaemia of varying severity. Five patients with SLC19A2 mutations suffered from thiamine-responsive megaloblastic anaemia and three exhibited the 'anaemia, deafness and diabetes' triad. Three patients with TRNT1 mutations exhibited severe early onset microcytic anaemia associated with thrombocytosis, and two exhibited B-cell immunodeficiency, inflammatory syndrome and psychomotor delay. The prognoses of patients with TRNT1 and SLC2A38 mutations were generally dismal because of comorbidities or severe iron overload. No molecular diagnosis could be established in 14/43 cases. This study emphasizes the frequency of ALAS2 and SLC25A38 mutations and provides the largest comprehensive analysis to date of genotype/phenotype correlations in CSA. Further studies of CSA patients with data recorded in an international registry would be helpful to improve patient management and establish standardized guidelines.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  congenital sideroblastic anaemia; genotype phenotype correlation; iron overload

Year:  2019        PMID: 31338833     DOI: 10.1111/bjh.16100

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

Review 1.  Clinical and Therapeutic Aspects of Sideroblastic Anaemia with B-Cell Immunodeficiency, Periodic Fever and Developmental Delay (SIFD) Syndrome: a Systematic Review.

Authors:  Ilaria Maccora; Athimalaipet V Ramanan; Daniel Wiseman; Edoardo Marrani; Maria V Mastrolia; Gabriele Simonini
Journal:  J Clin Immunol       Date:  2022-08-19       Impact factor: 8.542

Review 2.  SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.

Authors:  Matthew M Heeney; Simon Berhe; Dean R Campagna; Joseph H Oved; Peter Kurre; Peter J Shaw; Juliana Teo; Mayada A Shanap; Hoda M Hassab; Bertil E Glader; Sanjay Shah; Ayami Yoshimi; Afshin Ameri; Joseph H Antin; Jeanne Boudreaux; Michael Briones; Kathryn E Dickerson; Conrad V Fernandez; Roula Farah; Henrik Hasle; Sioban B Keel; Timothy S Olson; Jacquelyn M Powers; Melissa J Rose; Akiko Shimamura; Sylvia S Bottomley; Mark D Fleming
Journal:  Hum Mutat       Date:  2021-08-05       Impact factor: 4.878

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.